Shareholders' Deficit (Details) - USD ($) |
1 Months Ended | 2 Months Ended | 3 Months Ended | 12 Months Ended | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 01, 2022 |
Jan. 12, 2022 |
Jan. 06, 2022 |
Dec. 07, 2021 |
Oct. 15, 2021 |
May 01, 2021 |
Mar. 08, 2021 |
Feb. 01, 2021 |
Jan. 18, 2021 |
Jan. 07, 2021 |
Jan. 06, 2021 |
Dec. 12, 2019 |
Mar. 24, 2022 |
Aug. 25, 2021 |
Apr. 28, 2021 |
Mar. 19, 2021 |
Feb. 24, 2021 |
Aug. 20, 2020 |
Sep. 30, 2020 |
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Oct. 15, 2022 |
|
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Non-cash stock-based compensation | $ 957,556 | |||||||||||||||||||||||
| Accrued dividend payable | $ 21,500 | $ 16,641 | ||||||||||||||||||||||
| Stated value | $ 12,000 | |||||||||||||||||||||||
| Preferred stock, par value description | During the three months ended December 31, 2020, the Company entered into subscription agreements with an accredited investor whereby the investor agreed to purchase an aggregate of purchase 7,000 shares of the Company’s Series C Convertible Preferred Stock for $700,000, or $100.00 per share (the “Stated Value”), which were used from working capital purposes. | |||||||||||||||||||||||
| Restricted common shares (in Shares) | 14,250 | |||||||||||||||||||||||
| Value of restricted stock common shares | $ 0.0285 | |||||||||||||||||||||||
| Stock-based professional fees | 314,212 | $ 224,753 | ||||||||||||||||||||||
| Prepaid expenses | 111,800 | |||||||||||||||||||||||
| Stock-based professional fees | 111,800 | |||||||||||||||||||||||
| Stock-based professional fees | 43,250 | |||||||||||||||||||||||
| Prepaid expenses | 38,250 | |||||||||||||||||||||||
| Accretion of stock-based professional fees | 5,000 | |||||||||||||||||||||||
| Issued shares of common stock (in Shares) | 500,000 | |||||||||||||||||||||||
| Vested date | May 01, 2022 | |||||||||||||||||||||||
| Stock-based compensation expense on granted non-vested | 42,702 | 108,554 | ||||||||||||||||||||||
| Unrecognized compensation expense | $ 6,618 | |||||||||||||||||||||||
| Vesting period | 3 months | |||||||||||||||||||||||
| convertible debt description | 823,529 | |||||||||||||||||||||||
| Shares of common stock upon conversion (in Shares) | 823,529 | |||||||||||||||||||||||
| Accounts payable | $ 12,963 | |||||||||||||||||||||||
| Common shares per share (in Dollars per share) | $ 0.001 | $ 0.001 | ||||||||||||||||||||||
| Cashless exercise of warrants (in Shares) | 1,050,000 | |||||||||||||||||||||||
| Total unrecognized compensation expense related to unvested stock options | $ 0 | $ 0 | ||||||||||||||||||||||
| Warrant purchase, description | the Company issued 1,008,000 shares of its common stock in connection with the cashless exercise of 1,050,000 warrants. The exercise price was based on contractual terms of the related warrant. | |||||||||||||||||||||||
| 2018 Long-Term Incentive Plan [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Stock option, description | The aggregate number of shares of common stock and number of shares of the Company’s common stock that may be subject to incentive stock options granted under the 2018 Plan is 50,000,000 shares, of which 11,445,698 shares have been issued or granted under incentive stock options and 29,451,070 shares of restricted stock have been issued as of March 31, 2022. | |||||||||||||||||||||||
| Aggregate shares of common stock (in Shares) | 25,000,000 | |||||||||||||||||||||||
| Description of options to acquire common stock | The exercise price of options granted under our 2018 Plan must at least be equal to the fair market value of the Company’s common stock on the date of grant and the term of an option may not exceed ten years, except that with respect to an incentive stock option granted to any employee who owns more than 10% of the voting power of all classes of the Company’s outstanding stock as of the grant date the term must not exceed five years and the exercise price must equal at least 110% of the fair market value on the grant date. | |||||||||||||||||||||||
| Warrant [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Issued shares of common stock (in Shares) | 1,008,000 | |||||||||||||||||||||||
| Securities Purchase Agreements [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Warrant purchase, description | the Company issued warrants to purchase an aggregate amount up to 16,500,000 shares of the Company’s common stock (the “Warrants”). The Warrants were exercisable at any time on or after the date of the issuance and entitled this investor to purchase shares of the Company’s common stock for a period of five years from the initial date the warrants become exercisable. Under the terms of the Warrants, the holder was entitled to exercise the Warrants to purchase up to 16,500,000 shares of the Company’s common stock at an initial exercise price of $0.05, subject to adjustment as detailed in the Warrants. In connection with the issuance of these warrants, on the initial measurement date, the relative fair value of the warrants of $347,142 was recorded as a debt discount and an increase in paid-in capital (See Note 7). | |||||||||||||||||||||||
| Business Development [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Restricted common shares (in Shares) | 100,000 | |||||||||||||||||||||||
| Value of restricted stock common shares | $ 49,500 | $ 54,600 | $ 10,000 | |||||||||||||||||||||
| Common shares per share (in Dollars per share) | $ 0.066 | $ 0.078 | $ 0.1 | |||||||||||||||||||||
| Stock-based professional fees | 10,000 | |||||||||||||||||||||||
| Aggregate shares of common stock (in Shares) | 750,000 | 700,000 | ||||||||||||||||||||||
| Prepaid expenses | 37,700 | |||||||||||||||||||||||
| Series B Preferred Stock [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Designations established share (in Shares) | 100,000 | |||||||||||||||||||||||
| Preferred Stock par value (in Shares) | 0.1 | |||||||||||||||||||||||
| Stated value | $ 1,000 | |||||||||||||||||||||||
| Preferred Stock dividend rate | 2.00% | |||||||||||||||||||||||
| Stock option, description | The Series B is convertible into common stock at the option of a holder or if the closing price of the common stock exceeds 400% of the Conversion Price for a period of twenty consecutive trading days, at the option of the Company. Conversion Price means a price per share of the common stock equal to 100% of the lowest daily volume weighted average price of the common stock during the two years preceding or subsequent two years following the Issuance Date, subject to adjustment as otherwise provided in the Certificate of Designations (the “Conversion Price”). | |||||||||||||||||||||||
| Accrued compensation | $ 278,654 | $ 295,000 | ||||||||||||||||||||||
| Accrued compensation shares (in Shares) | 278 | 295 | ||||||||||||||||||||||
| Stock based compensation | $ 3,778,810 | |||||||||||||||||||||||
| Vested shares (in Shares) | 158 | |||||||||||||||||||||||
| Accrued dividend payable | $ 4,858 | 3,286 | ||||||||||||||||||||||
| Preferred stock balance | 1,022,123 | 738,611 | ||||||||||||||||||||||
| Stated value | 1,000,623 | 721,970 | ||||||||||||||||||||||
| Series C Preferred Stock [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Designations established share (in Shares) | 100,000 | |||||||||||||||||||||||
| Preferred Stock par value (in Shares) | 0.1 | 630,000 | ||||||||||||||||||||||
| Stated value | $ 100 | 1,868,000 | ||||||||||||||||||||||
| Preferred Stock dividend rate | 2.00% | |||||||||||||||||||||||
| Accrued dividend payable | $ 1,509,523 | $ 2,845,238 | $ 48,159 | 39,012 | ||||||||||||||||||||
| Preferred stock balance | $ 1,904,159 | $ 1,907,012 | ||||||||||||||||||||||
| Stated value | $ 12,000 | $ 12,000 | ||||||||||||||||||||||
| Percentage of stated value | 150.00% | |||||||||||||||||||||||
| Outstanding shares percent | 4.99% | |||||||||||||||||||||||
| Aggregate shares purchase (in Shares) | 6,300 | |||||||||||||||||||||||
| Preferred stock stated value (in Dollars per share) | $ 100 | |||||||||||||||||||||||
| Purchase of shares (in Shares) | 3,000 | 2,500 | ||||||||||||||||||||||
| Share issued (in Shares) | 1,543,151 | 1,500,000 | ||||||||||||||||||||||
| Common shares converted (in Shares) | 120 | 120 | ||||||||||||||||||||||
| Stated value | $ 1,856,000 | |||||||||||||||||||||||
| Issued shares of common stock (in Shares) | 120 | |||||||||||||||||||||||
| Company issued (in Shares) | 1,543,151 | |||||||||||||||||||||||
| Series C Preferred Stock [Member] | Preferred Stock Dividends [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Accrued dividend payable | $ 9,147 | 7,052 | ||||||||||||||||||||||
| Series C Convertible Preferred Stock [Member] | Maximum [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Stated value | $ 300,000 | $ 250,000 | ||||||||||||||||||||||
| Series C Convertible Preferred Stock [Member] | Minimum [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Stated value | $ 100 | $ 100 | ||||||||||||||||||||||
| Forecast [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Preferred stock stated value (in Dollars per share) | $ 0.0125 | |||||||||||||||||||||||
| Forecast [Member] | Series B Preferred Stock [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Vested shares (in Shares) | 842 | |||||||||||||||||||||||
| Sales Manager [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Common shares per share (in Dollars per share) | $ 0.078 | |||||||||||||||||||||||
| Issued shares of common stock (in Shares) | 200,000 | |||||||||||||||||||||||
| Value of issued shares of common stock | $ 15,600 | |||||||||||||||||||||||
| Officer [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Restricted common shares (in Shares) | 2,500,000 | |||||||||||||||||||||||
| Value of restricted stock common shares | $ 165,000 | |||||||||||||||||||||||
| Common shares per share (in Dollars per share) | $ 0.066 | |||||||||||||||||||||||
| Shares Issued for Accounts Payable [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Company issued (in Shares) | 90,859 | |||||||||||||||||||||||
| Accounts payable | $ 2,174 | |||||||||||||||||||||||
| Common shares per share (in Dollars per share) | $ 0.024 | |||||||||||||||||||||||
| Advisory and Consulting Services [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Stock-based professional fees | 16,900 | |||||||||||||||||||||||
| Consulting Agreement [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Stock-based professional fees | 20,167 | |||||||||||||||||||||||
| Prepaid expenses | $ 29,333 | |||||||||||||||||||||||
| General Release Agreement [Member] | ||||||||||||||||||||||||
| Shareholders' Deficit (Details) [Line Items] | ||||||||||||||||||||||||
| Accrued compensation | $ 40,625 | |||||||||||||||||||||||
| Common shares per share (in Dollars per share) | $ 0.059 | |||||||||||||||||||||||
| Issued shares of common stock (in Shares) | 944,767 | |||||||||||||||||||||||
| Value of issued shares of common stock | $ 55,741 | |||||||||||||||||||||||
| Stock-based compensation | $ 15,116 | |||||||||||||||||||||||